As of Oct 2, 2026 close
- Market cap
- $3.52B
- P/E (TTM)
- —
- Forward P/E
- —
- Dividend yield
- —
- 52-week range
- $0.15$21.46
- Volume (live)
- —
- Avg. volume (3M)
- 334.17K
Gossamer Bio (GOSS) Stock Price & Financial Analysis
Gossamer Bio Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $10.19 - $11.19 |
|---|---|
| 52-Week High | $21.46 |
| 52-Week Low | $0.15 |
| Open | $11.19 |
| Volume (last close) | 235.00K |
| Average Volume (3M) | 334.17K |
| Market Cap | 3.52B |
|---|---|
| Shares Outstanding | 328.78M |
| Price to Sales (P/S) | 66.08 |
| Price to Book (P/B) | -37.45 |
| EV/EBITDA | -31.03 |
| Revenue (TTM) | 53.29M |
|---|---|
| Net Income (TTM) | -125.22M |
| Free Cash Flow (TTM) | -162.63M |
| EPS (TTM) | $-0.89 |
| Profit Margin | -235.00% |
| Operating Margin | -297.67% |
| 50-Day MA | $12.89 |
|---|---|
| 200-Day MA | $5.93 |
| 52-Week Change | +331.85% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Gossamer Bio at a Glance
Gossamer Bio (GOSS) has a market capitalization of $3.52B. The stock trades at 66.1× sales. Over the trailing twelve months it lost $125.22M on revenue of $53.29M and burned $162.63M of free cash flow. Revenue grew 32.4% year over year.
It holds $41.15M in cash and securities against $39.10M of debt, a net cash position of $2.04M.
Gossamer Bio does not currently pay a dividend.
The share price is up 316.7% over the past year. At $10.71 it sits within its 52-week range of $0.15 to $21.46, above its 200-day moving average of $5.93.
Based on 2 professional analyst ratings from the past 90 days, the consensus is Hold.
Frequently Asked Questions About Gossamer Bio
What is the current stock price for GOSS?
As of the Oct 2, 2026 close, GOSS stock trades at $10.71. The 52-week range is $0.15–$21.46, with a day range of $10.19–$11.19.
What is the P/E ratio for GOSS?
The P/E ratio (Price-to-Earnings) for GOSS is shown in the Key Statistics section. This valuation metric helps compare Gossamer Bio, Inc. to industry peers.
Does GOSS pay dividends?
Gossamer Bio does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for GOSS?
Based on 2 analysts, the consensus for GOSS is Hold.
What is the market cap of GOSS?
Gossamer Bio's market capitalization is $3.52B, classifying it as a mid-cap company. Gossamer Bio operates in the Healthcare sector within the Biotechnology industry.